IBUPROFEN SODIUM

Post-LOE

ibuprofen sodium

Design Pharmaceuticals

ANDAORALTABLET

Approved

Aug 2015

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

IBUPROFEN SODIUM (ibuprofen sodium) by Design Pharmaceuticals. Approved for minor aches, pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever. First approved in 2015.

Drug data last refreshed Yesterday

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (2)

minor aches pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever

Worked on IBUPROFEN SODIUM at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

IBUPROFEN SODIUM

Mechanism of Action

Indications (2)

Clinical Trials (1)